GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirnaomics Ltd (HKSE:02257) » Definitions » Net Interest Income (for Banks)

Sirnaomics (HKSE:02257) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is Sirnaomics Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


Sirnaomics Business Description

Industry
Traded in Other Exchanges
Address
No.218 Xinghu Street, Unit 415, A4 Building, Suzhou Industrial Park, Suzhou, CHN
Sirnaomics Ltd is a therapeutics biopharmaceutical company with product candidates in preclinical and clinical stages that focuses on the discovery and development of drugs for indications with medical needs and large market opportunities. The Group's operations and non-current assets are located at the United States of America and the mainland of the People's Republic of China.
Executives
Poon Hung Fai 2101 Beneficial owner
Lu Yang 2101 Beneficial owner
Jpmorgan Chase & Co. 2201 Interest of corporation controlled by you
Dai Xiaochang 2201 Interest of corporation controlled by you
Yan Xia Ling 2202 Interest of your spouse
Ceng Yu 2201 Interest of corporation controlled by you
Li Jie 2201 Interest of corporation controlled by you
Li Lele 2202 Interest of your spouse
Shanghai Chongshi Enterprise Management Partnership(lp) 2101 Beneficial owner
Shenzhen Qianhai Rotating Boulder Fund Management Co.,ltd 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Second Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shenzhen Rotating Boulder Tiancheng The Third Investment Partnership (limited Partnership) 2201 Interest of corporation controlled by you